We are live on
!
Find out more
GIM
Granahan Investment Management Portfolio holdings
AUM
$2.07B
1-Year Est. Return
56.45%
This Fund
S&P 500
This Quarter
Est. Return
+53.18%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$4.46B
AUM Growth
+$1.51B
(+51%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
7.28%
Top 10 Holdings %
Top 10 Hldgs %
35.21%
Holding
208
New
28
Increased
93
Reduced
71
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workiva
WK
|
+$52.1M |
| 2 |
Kulicke & Soffa
KLIC
|
+$40.4M |
| 3 |
DMYD
dMY Technology Group, Inc. II
DMYD
|
+$39.8M |
| 4 |
MSP
Datto Holding Corp.
MSP
|
+$35.7M |
| 5 |
VIEW
View, Inc. Class A Common Stock
VIEW
|
+$29.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnite
MGNI
|
+$50.1M |
| 2 |
Trade Desk
TTD
|
+$41.3M |
| 3 |
PS
Pluralsight, Inc. Class A Common Stock
PS
|
+$33.7M |
| 4 |
Paylocity
PCTY
|
+$31M |
| 5 |
Sonic Automotive
SAH
|
+$25.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.6% |
| 2 | Healthcare | 16.36% |
| 3 | Industrials | 13.09% |
| 4 | Consumer Discretionary | 9.99% |
| 5 | Communication Services | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nutanix
NTNX
$17.4B
| $13.1M | 0.3% |
412,449
+190,698
| +86% | +$5.17M |
|
77
Materion
MTRN
$5.88B
| $12.7M | 0.29% |
199,899
-32,636
| -14% | -$1.88M |
|
78
Titan Machinery
TITN
$445M
| $12.3M | 0.28% |
630,606
-110,640
| -15% | -$1.9M |
|
79
RBC Bearings
RBC
$17.7B
| $12.1M | 0.27% |
67,523
-26,028
| -28% | -$3.97M |
|
|
ESPR
80
DELISTED
Esperion Therapeutics
ESPR
| $11.7M | 0.26% |
450,398
-37,701
| -8% | -$1.13M |
|
|
GNMK
81
DELISTED
GenMark Diagnostics, Inc
GNMK
| $11.6M | 0.26% |
+794,825
| New | +$10.5M |
|
82
Insmed
INSM
$29.2B
| $11.6M | 0.26% |
347,981
-66,863
| -16% | -$2.44M |
|
|
VAPO
83
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $11.5M | 0.26% |
53,743
+30,869
| +135% | +$6.89M |
|
84
Organogenesis Holdings
ORGO
$235M
| $11.2M | 0.25% |
1,488,485
+736,597
| +98% | +$3.5M |
|
|
BPMC
85
DELISTED
Blueprint Medicines
BPMC
| $11M | 0.25% |
97,782
-30,777
| -24% | -$3.24M |
|
86
Editas Medicine
EDIT
$458M
| $10.9M | 0.24% |
155,202
-28,038
| -15% | -$1.15M |
|
87
Varonis Systems
VRNS
$4.85B
| $10.6M | 0.24% |
194,997
+73,965
| +61% | +$3.21M |
|
88
Ciena
CIEN
$54.8B
| $10.6M | 0.24% |
199,737
+9,392
| +5% | +$417K |
|
|
AFMD
89
DELISTED
Affimed
AFMD
| $10.5M | 0.24% |
+181,017
| New | +$8.52M |
|
|
TPTX
90
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $10.5M | 0.24% |
86,294
-8,670
| -9% | -$950K |
|
91
Gentherm
THRM
$1.29B
| $10.5M | 0.24% |
+161,057
| New | +$8.69M |
|
92
PROG Holdings
PRG
$1.66B
| $10M | 0.23% |
186,087
+45,224
| +32% | +$2.33M |
|
93
WillScot Mobile Mini Holdings
WSC
$4.23B
| $10M | 0.22% |
431,457
-176,743
| -29% | -$3.56M |
|
94
Enanta Pharmaceuticals
ENTA
$387M
| $9.73M | 0.22% |
231,071
+42,907
| +23% | +$1.89M |
|
95
Beam Therapeutics
BEAM
$2.78B
| $9.31M | 0.21% |
114,058
+18,773
| +20% | +$923K |
|
|
EPZM
96
DELISTED
Epizyme, Inc
EPZM
| $9.28M | 0.21% |
854,096
+452,240
| +113% | +$5.58M |
|
97
AtriCure
ATRC
$2.16B
| $9.19M | 0.21% |
+165,107
| New | +$7.14M |
|
98
CEVA Inc
CEVA
$861M
| $9.17M | 0.21% |
201,453
+53,789
| +36% | +$2.21M |
|
99
Plug Power
PLUG
$3.11B
| $9.1M | 0.2% |
268,380
-48,748
| -15% | -$1.1M |
|
100
Texas Capital Bancshares
TCBI
$4.35B
| $8.89M | 0.2% |
149,410
-11,296
| -7% | -$558K |
|
Similar funds
BC
AG
TA
ACP
TP
NSUP
ACG
CL
Granahan Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Granahan Investment Management held 208 positions worth $4.46B, up 51% from $2.95B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Granahan Investment Management deployed $324M of net new capital in Q4 2020, opening 28 new positions and adding to 93 existing holdings. Its largest new stake was dMY Technology Group, Inc. II: 3,436,892 shares worth $60.5M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Magnite, an estimated $50.1M trimmed.
- Granahan Investment Management's largest Q4 2020 buy was dMY Technology Group, Inc. II: 3,436,892 shares worth $60.5M.
- Granahan Investment Management added most to Workiva in Q4 2020, an estimated $52.1M increase.
- Granahan Investment Management's biggest Q4 2020 reduction was Magnite, cutting an estimated $50.1M.
- Granahan Investment Management fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $33.7M.
- Granahan Investment Management's ten largest holdings make up 35% of its $4.46B portfolio in Q4 2020.
- Granahan Investment Management opened 28 new positions and closed 16 in Q4 2020.
- Granahan Investment Management's portfolio value rose 51% quarter-over-quarter to $4.46B.
Based on Granahan Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.